Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 2
2015 1
2018 3
2019 1
2020 1
2021 1
2022 2
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

12 results

Results by year

Filters applied: . Clear all
Page 1
Functional antigen processing and presentation mechanism as a prerequisite factor of response to treatment with dendritic cell vaccines and anti-PD-1 in preclinical murine LLC1 and GL261 tumor models.
Žilionytė K, Bagdzevičiūtė U, Mlynska A, Urbštaitė E, Paberalė E, Dobrovolskienė N, Krasko JA, Pašukonienė V. Žilionytė K, et al. Among authors: mlynska a. Cancer Immunol Immunother. 2022 Nov;71(11):2691-2700. doi: 10.1007/s00262-022-03190-9. Epub 2022 Apr 1. Cancer Immunol Immunother. 2022. PMID: 35364740 Free PMC article.
A gene signature for immune subtyping of desert, excluded, and inflamed ovarian tumors.
Mlynska A, Vaišnorė R, Rafanavičius V, Jocys S, Janeiko J, Petrauskytė M, Bijeikis S, Cimmperman P, Intaitė B, Žilionytė K, Barakauskienė A, Meškauskas R, Paberalė E, Pašukonienė V. Mlynska A, et al. Am J Reprod Immunol. 2020 Jul;84(1):e13244. doi: 10.1111/aji.13244. Epub 2020 May 9. Am J Reprod Immunol. 2020. PMID: 32294293
Correction to: Functional antigen processing and presentation mechanism as a prerequisite factor of response to treatment with dendritic cell vaccines and anti-PD-1 in preclinical murine LLC1 and GL261 tumor models.
Žilionytė K, Bagdzevičiūtė U, Mlynska A, Urbštaitė E, Paberalė E, Dobrovolskienė N, Krasko JA, Pašukonienė V. Žilionytė K, et al. Among authors: mlynska a. Cancer Immunol Immunother. 2022 Nov;71(11):2701. doi: 10.1007/s00262-022-03207-3. Cancer Immunol Immunother. 2022. PMID: 35467108 Free PMC article. No abstract available.
Defining Melanoma Immune Biomarkers-Desert, Excluded, and Inflamed Subtypes-Using a Gene Expression Classifier Reflecting Intratumoral Immune Response and Stromal Patterns.
Mlynska A, Gibavičienė J, Kutanovaitė O, Senkus L, Mažeikaitė J, Kerševičiūtė I, Maskoliūnaitė V, Rupeikaitė N, Sabaliauskaitė R, Gaiževska J, Suveizdė K, Kraśko JA, Dobrovolskienė N, Paberalė E, Žymantaitė E, Pašukonienė V. Mlynska A, et al. Biomolecules. 2024 Jan 31;14(2):171. doi: 10.3390/biom14020171. Biomolecules. 2024. PMID: 38397409 Free PMC article.
Accumulation and biological effects of cobalt ferrite nanoparticles in human pancreatic and ovarian cancer cells.
Pašukonienė V, Mlynska A, Steponkienė S, Poderys V, Matulionytė M, Karabanovas V, Statkutė U, Purvinienė R, Kraśko JA, Jagminas A, Kurtinaitienė M, Strioga M, Rotomskis R. Pašukonienė V, et al. Among authors: mlynska a. Medicina (Kaunas). 2014;50(4):237-44. doi: 10.1016/j.medici.2014.09.009. Epub 2014 Oct 6. Medicina (Kaunas). 2014. PMID: 25458961 Free article.
12 results